5 August 2021 - Newsletter

c-LEcta, one of the leading enzyme specialists, for the first time with 10 million euros turnover per year

The company c-LEcta is one of the world’s leading biotech companies in the field of enzyme production. More than 200 customers in 40 countries, including well-known pharmaceutical companies, rely on the enzyme products from Leipzig. 2020 was a successful year for c-LEcta, in which the 10 million euro mark in turnover was broken for the first time. EBITDA also improved strongly to 2 million euros. The top seller and growth driver is the enzyme DENARASE, which is also used by manufacturers of vector-based corona vaccines.

More information: t1p.de